SCHEMBL2072157

SCHEMBL2072157

O=S(=O)(Cc1nc2ccccc2s1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 1.00
RAB9A P51151 3/20 1.00
NPC1 O15118 2/20 1.00
KDM4E B2RXH2 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
PKM P14618 1/20 0.54
ALDH1A1 P00352 4/20 0.53
HTT P42858 3/20 0.53
GAA P10253 1/20 0.53
UBE2T Q9NPD8 1/20 0.53
ASIC3 Q9UHC3 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.50
ALOX15 P16050 1/20 0.50
MAPK1 P28482 1/20 0.50
KMT2A Q03164 4/20 0.49
HPGD P15428 2/20 0.49
PSMB8 P28062 1/20 0.47
PSMB5 P28074 1/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11336688 0.88 SMN1; SMN2 (0.78) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL11334684 0.88 SMN1; SMN2 (0.78) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL10367346 0.83 SMN1; SMN2 (0.71) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL16899350 0.83 NPC1 (0.70) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL28795915 0.81 SMN1; SMN2 (0.69) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL1272747 0.80 SMN1; SMN2 (0.67) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL1272745 0.80 SMN1; SMN2 (0.67) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL11327660 0.79 SMN1; SMN2 (0.66) SMN1; SMN2RAB9ANPC1KDM4ETDP1
SCHEMBL13604243 0.74 CYP1A2 (0.59) SMN1; SMN2RAB9ANPC1TDP1ALDH1A1
SCHEMBL10370401 0.73 KDM4E (0.65) SMN1; SMN2RAB9ANPC1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906546-B2 Tetrahydrocarbazoles and derivatives HOFFMANN-LA ROCHE INC. (US) 2011-03-15 US disclosed
US-20100216833-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES DEHMLOW HENRIETTA 2010-08-26 US disclosed
EP-1732892-B1 TETRAHYDROCARBAZOLES AND DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-09-17 EP disclosed
EP-1732892-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-12-20 EP disclosed
WO-2005092856-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-10-06 WO disclosed
US-20050215577-A1 Tetrahydrocarbazoles and derivatives HOFFMANN-LA ROCHE INC. 2005-09-29 US disclosed
US-4260770-A Naphtholactam dyes CIBA-GEIGY AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed
US-4256896-A THIAZOLE, IMIDAZOLINE, AND OXAZOLINE DYES; DISPERSE DYES; ANIONIC DYES; TEXTILES CIBA-GEIGY AKTIENGESELLSCHAFT (DE) 1981-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216833-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES NR1H3, NR1H2, NR1H4 SMN1; SMN2 1648/4885RAB9A 3611/4885NPC1 92/4885
US-20050215577-A1 Tetrahydrocarbazoles and derivatives NR1H3, NR1H2, NR1H4 SMN1; SMN2 1648/4885RAB9A 3611/4885NPC1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.